scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Characteristics of Adults with Attention Deficit Hyperactivity Disorder Plus Substance Use Disorder: The Role of Psychiatric Comorbidity

TL;DR: Clinicians need to be attentive to other psychiatric disorders that may occur in the large group of adults with ADHD + SUD, especially mood and anxiety disorders, which exist in subjects with SUD + ADHD relative to subjects withSUD, ADHD, or controls.
Journal ArticleDOI

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

TL;DR: Differences in the pathophysiology of the combined versus the predominantly inattentive animal model of ADHD are suggested and treatment with methylphenidate might reduce elevated DAT levels more effectively in the combined subtype especially when applied before puberty.
Journal ArticleDOI

Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.

TL;DR: An exploratory stratification by gender suggests that long‐repeat alleles of DRD4 and DAT1 may increase the risk for ADHD in Han Chinese children.
Journal ArticleDOI

Adult attention deficit hyperactivity disorder.

TL;DR: Overall, stimulant drugs are associated with an improvement in symptoms and there is little data on the long-term safety of stimulants in older adults (50+) with medical conditions.
Journal Article

Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

TL;DR: Books about the effects of stimulant therapy on substance use disorders and the potential for misuse and diversion of stimulants are reviewed to suggest long-acting stimulants may be less likely to be misused or diverted.